Skip to main content
. 2015 Aug 21;20(8):15287–15303. doi: 10.3390/molecules200815287

Table 1.

Cyclooxgenanse (COX-1 and COX-2) inhibitory activity.

Compd. No. Drug in μg/mL Percentage Inhibition * COX-2/COX-1 Selectivity
COX-1 COX-2
5a 10 3.88 ± 0.0023 36.51 ± 0.35 9.4
5b 10 3.84 ± 0.0034 59.11 ± 0.44 15.4
5c 10 3.76 ± 0.0023 68.34 ± 0.53 18.2
5d 10 3.80 ± 0.0032 67.72 ± 0.44 17.8
5e 10 3.92 ± 0.0023 75.92 ± 0.36 19.4
5f 10 3.96 ± 0.0034 25.31 ± 0.40 6.4
5g 10 3.99 ± 0.0025 24.72 ± 0.59 6.2
5h 10 3.62 ± 0.0036 20.85 ± 0.38 5.6
5i 10 3.58 ± 0.0025 11.50 ± 0.47 3.2
5j 10 3.54 ± 0.0034 22.15 ± 0.65 6.6
5k 10 3.51 ± 0.0046 12.80 ± 0.74 3.6
5l 10 3.69 ± 0.0027 9.58 ± 0.83 2.5
Diclofenac 10 56.78 7.88 0.13
Valdecoxib 10 12.15 76.15 6.26
Ibuprofen 10 78.89 5.23 0.06

Values were calculated from the mean values of data from three separate experiments and presented as mean ± S.E.M.; * The percentage Inhibition is the percent in inhibition of the either COX enzyme activities at the selected doses; All results are significant different from control values at p ≤ 0.005; All results are significant different from reference standard values at p ≤ 0.005.